What is Brightside Scientific?
Brightside Scientific operates as a state-of-the-art cannabis testing laboratory, leveraging decades of experience and holding ISO/IEC 17025:2017 accreditation. The company provides a comprehensive suite of testing services, encompassing cannabinoid potency, heavy metal analysis, and microbiological contaminant detection. Prioritizing safety and quality for both medical and recreational cannabis products, Brightside Scientific's expert team ensures reliable results and adherence to California state regulations. This commitment to precision positions them as a key player in ensuring product integrity within the burgeoning cannabis market.
How much funding has Brightside Scientific raised?
Brightside Scientific has raised a total of $62K across 1 funding round:
Debt
$62K
Debt (2021): $62K with participation from PPP
Key Investors in Brightside Scientific
PPP
Public-Private Partnership
What's next for Brightside Scientific?
With this latest round of expansion capital, Brightside Scientific is poised for significant scaling and further enhancement of its testing capabilities. The substantial investment suggests a strategic focus on expanding market reach, potentially through new laboratory facilities or advanced technological integrations. This financing will likely fuel innovation in analytical methods and reinforce their compliance infrastructure, solidifying their leadership in providing critical safety and quality assurance for cannabis products. The company's trajectory indicates a strong potential for further growth and market penetration in the highly regulated cannabis industry.
See full Brightside Scientific company page
